Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or

@inproceedings{Mithoefer2012DurabilityOI,
  title={Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or},
  author={Michael C. Mithoefer and Mark T. Wagner and Ann T Mithoefer and Lisa Jerome and Scott F Martin and B Berra Yazar-Klosinski and Yvonne Michel and Timothy D. Brewerton and Rick Doblin},
  year={2012}
}
We report follow-up data evaluating the long-term outcomes for the first completed trial of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment-resistant post-traumatic stress disorder (PTSD) (Mithoefer et al., 2011). All of the 19 subjects who received MDMA-assisted treatment in the original trial participated in the long-term follow-up (LTFU), with 16 out of 19 completing all of the long-term outcome measures, which were administered from 17 to 74 months… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 85 references

MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder: A revised teaching manual draft

  • MC Mithoefer, L Jerome, JM Ruse
  • Available at: http://www.maps.org/research/ mdma…
  • 2011
Highly Influential
9 Excerpts

Certificates of confidentiality kiosk

  • MA Hertzberg, ME Feldman, JC Beckham
  • 2011

Similar Papers

Loading similar papers…